Kyowa Kirin Co.,Ltd.
Develops antibody medicines for oncology, nephrology, immunology, and allergy.
4151 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 千代田区大手町一丁目９番２号
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kyowa Kirin is a global specialty pharmaceutical company dedicated to addressing unmet medical needs through innovative drug discovery. The company engages in the research, development, manufacturing, and commercialization of pharmaceuticals and biotechnology products. Focusing on core therapeutic areas such as nephrology, oncology, immunology, and allergy, Kyowa Kirin leverages its advanced antibody technologies to create novel medicines. Guided by its mission of "Commitment to Life," the organization strives to deliver life-changing value to patients, their families, and medical professionals worldwide by developing and marketing innovative prescription drugs that contribute to global health and well-being.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Kyowa Kirin Co.,Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-31 08:30 |
Interim Report
半期報告書－第103期(2025/01/01－2025/12/31)
|
Japanese | 991.7 KB | |
| 2025-07-31 08:30 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-07-11 09:30 |
Regulatory News Service
臨時報告書
|
Japanese | 21.2 KB | |
| 2025-03-21 06:47 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 46.5 KB | |
| 2025-03-21 06:41 |
Regulatory News Service
臨時報告書
|
Japanese | 26.8 KB | |
| 2025-03-19 07:51 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 56.3 KB | |
| 2025-03-11 07:31 |
Annual Report
有価証券報告書－第102期(2024/01/01－2024/12/31)
|
Japanese | 4.0 MB | |
| 2025-03-11 07:31 |
Regulatory News Service
内部統制報告書－第102期(2024/01/01－2024/12/31)
|
Japanese | 22.5 KB | |
| 2025-03-11 07:31 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-11-14 07:30 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 26.6 KB | |
| 2024-10-31 07:30 |
Regulatory News Service
臨時報告書
|
Japanese | 26.1 KB | |
| 2024-10-11 08:30 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.9 KB | |
| 2024-09-12 08:32 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 28.2 KB | |
| 2024-08-09 08:30 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 26.1 KB | |
| 2024-08-01 08:31 |
Interim Report
半期報告書－第102期(2024/01/01－2024/12/31)
|
Japanese | 916.7 KB |
Automate Your Workflow. Get a real-time feed of all Kyowa Kirin Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Kyowa Kirin Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
